Defining pre-emptive living kidney donor transplantation as a quality indicator
Wang C, Garg AX, Luo B, Kim SJ, Knoll G, Yohanna S, Treleaven D, McKenzie S, Ip J, Cooper R, Elliott L, Naylor KL. Am J Transplant. 2024; Feb 20 [Epub ahead of print].
Publications
Mental health and addiction service utilization among people living with chronic kidney disease
Bhasin AA, Molnar AO, McArthur E, Nash DM, Busse JW, Cooper R, Heale E, Ip J, Pang J, Blake PG, Garg AX, Kurdyak P, Kim SJ, Sultan H, Walsh M. Nephrol Dial Transplant. 2023; Nov 28 [Epub ahead of print].
Low-dose methotrexate and serious adverse events among older adults with chronic kidney disease
Muanda FT, Blake PG, Weir MA, Ahmadi F, McArthur E, Sontrop JM, Urquhart BL, Kim RB, Garg AX. JAMA Netw Open. 2023; 6(11):e2345132. Epub 2023 Nov 27.
Patient care gaps prior to maintenance dialysis initiation: a population-based retrospective study
Molnar AO, Nash DM, Emblem J, Bota S, McArthur E, Luo B, Liu Y, Garg AX, Blake PG, Brimble KS. Can J Kidney Health Dis. 2023; Nov 17 [Epub ahead of print].
Effect of a novel multicomponent intervention to improve patient access to kidney transplant and living kidney donation: the ENAKT LKD cluster randomized clinical trial
Garg AX, Yohanna S, Naylor KL, McKenzie SQ, Mucsi I, Dixon SN, Luo B, Sontrop JM, Beaucage M, Belenko D, Coghlan C, Cooper R, Elliott L, Getchell L, Heale E, Ki V, Nesrallah G, Patzer RE, Presseau J, Reich M, Treleaven D, Wang C, Waterman AD, Zaltzman J, Blake PG. JAMA Intern Med. 2023; Nov 3 [Epub ahead of print].
Breast cancer screening, incidence and mortality in women treated with maintenance dialysis: a population-based cohort study in Ontario, Canada
Saleem N, Nash DM, Au E, Luo B, Craig JC, Garg AX, McArthur E, Dixon SN, Teixeira-Pinto A, Lim WH, Wong G. Kidney Int Rep. 2023; Oct 17 [Epub ahead of print].
Adverse events with quetiapine and clarithromycin coprescription: a population-based retrospective cohort study
Yau K, McArthur E, Jeyakumar N, Muanda FT, Kim RB, Clemens KK, Wald R, Garg AX. Health Sci Rep. 2023; 6(6):e1375. Epub 2023 Jun 23.
Variation in kidney transplant referral across chronic kidney disease programs in Ontario, Canada
Yohanna S, Naylor KL, Luo B, Dixon SN, Bota SE, Kim SJ, Blake PG, Elliott L, Cooper R, Knoll GA, Treleaven D, Wang C, Garg AX. Can J Kidney Health Dis. 2023; 10:20543581231169608. Epub 2023 Jun 14.
Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis
Situ M, Schwarz UI, Zou G, McArthur E, Kim RB, Garg AX, Sarma S. Eur J Health Econ. 2023; May 17 [Epub ahead of print].
Safety and effectiveness of rivaroxaban versus warfarin across GFR levels in atrial fibrillation: a population-based study in Australia and Canada
Ha JT, Scaria A, Andrade J, Badve SV, Birks P, Bota SE, Campain A, Djurdjev O, Garg AX, Harel Z, Hemmelgarn B, Hockham C, James MT, Jardine MJ, Lam D, Levin A, McArthur E, Ravani P, Shao S, Sood MM, Tan Z, Tangri N, Whitlock R, Gallagher M, Jun M. Kidney Med. 2023; 5(7):100675. Epub 2023 May 16.